Implementing the COVID-19 Rapid Community Assessment on Vaccine Confidence: Lessons Learned From Alabama and Georgia

Engaging communities is a key strategy to increase COVID-19 vaccination. The Centers for Disease Control and Prevention (CDC) COVID-19 Vaccine Confidence Rapid Community Assessment Guide was developed for community partners to obtain insights about barriers to COVID-19 vaccine uptake and to engage community partners in designing interventions to build vaccine confidence. In spring 2021, 3 CDC teams were deployed to Alabama and Georgia to conduct a rapid community assessment in selected jurisdictions. Data collection included interviews, listening sessions, observations, and street intercept surveys. We identified 3 facilitators and barriers to vaccine uptake: (1) planning and coordination, (2) capacity and implementation, and (3) attitudes and beliefs. We found that the use of the rapid community assessment in Alabama and Georgia was feasible to implement, useful in eliciting unique community concerns and dispelling assumptions, and useful in informing intervention strategies. Our results underscore the importance of community engagement in COVID-19 mitigation strategies.

[1]  J. Anesi The advisory Committee on Immunization practices’ updated interim recommendation for allocation of COVID-19 vaccine—United states, December 2020 , 2021, American Journal of Transplantation.

[2]  J. Tate,et al.  Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[3]  J. Khubchandani,et al.  COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment , 2021, Journal of Community Health.

[4]  B. Bell,et al.  The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[5]  J. Gargano,et al.  The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[6]  J. Gargano,et al.  The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[7]  S. Kreps,et al.  Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination , 2020, JAMA network open.

[8]  S. Crawford,et al.  Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults , 2020, Annals of Internal Medicine.

[9]  A. Zekeri The Causes of Enduring Poverty in Alabama ’ s Black Belt * , 2004 .